Real-world Cost per Responder Among Different Classes of Biologics for the Treatment of Psoriasis

Real-world Cost per Responder Among Different Classes of Biologics for the Treatment of Psoriasis

Although biologics have revolutionized psoriasis treatment, they pose a significant burden on the healthcare budget. With the wide range of biologics available and the increasing number of biosimilars, insights into the real-world cost per responder (CPR) are required. Therefore, this study aims to...

Full description

Saved in:
Bibliographic Details
Main Authors: Linda T.H. Godding, Marieke M.B. Seyger, Albert Duvetorp, Marisol E. Otero, Paul M. Ossenkoppele, Annet M. Oostveen, M. Birgitte Visch, Ella A.M. van der Voort, John E.M. Körver, Lizelotte J.M.T. Weppner-Parren, Maartje A.M. Berends, W. Peter Arnold, Sharon R.P. Dodemont, Astrid L.A. Kuijpers, Johannes M. Mommers, Femke M. Homan, Antoni H. Gostynski, Berit Velstra, Marloes M. Kleinpenning, Martijn B.A. van Doorn, Romy R.M.C. Keijsers, Else N. Kop, Inge M. Haeck, Judith H.J. Hendricksen-Roelofzen, Douwe Vellinga, Elke M.G.J. de Jong, Juul M.P.A. van den Reek
Format: Article
Language:English
Published: Medical Journals Sweden 2025-06-01
Series:Acta Dermato-Venereologica
Subjects:
Biologics
cost-effectiveness
cost per responder
observational studies
psoriasis
real-world evidence
Online Access:https://medicaljournalssweden.se/actadv/article/view/42767
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://medicaljournalssweden.se/actadv/article/view/42767

Similar Items